Biomanufacturing World Summit is the industry’s leading collection of manufacturing executives, thought leaders and innovators. We offer sponsors bespoke value added services tailored around your ability to pre-select prospects to meet with face-to-face.
If you are interested in learning more about sponsorship opportunities please call our Sponsorship Division at 416-829-6500 or email us at info@executiveplatforms.com.
Samsung Biologics is a fully integrated CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry. With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.
Our plants are cGMP compliant with a wide range of bioreactor scales to serve varying client needs and meet growing market demand. We hold a total capacity of 604KL at Bio Campus I, the world’s largest biomanufacturing site, and have announced plans to construct a fifth plant, which will be operational in April 2025.
From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world’s leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. Follow us on LinkedIn. For more information, visit azzur.com
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’ proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, Calif.
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman and Xcellerex. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.
FUJIFILM Diosynth Biotechnologies is an industry-leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting the biopharmaceutical industry in the development and production of biologics, vaccines and advanced therapies. Our focus is to combine technical leadership in process development and cGMP manufacturing supported by a strong team of over 4,000 employees and a reputation for excellent customer service. We are a trusted partner of many clients, from early stage biotechs to large pharma.
IDBS provides cloud-based solutions to meet the unique data management challenges faced by Life Sciences teams throughout the product and process lifecycle and across the supply chain. Our innovative Polar platform is the industry’s first digital data backbone enabling customers in research, development and manufacturing to efficiently and compliantly access critical data and insights to make faster, smarter decisions with greater confidence.
IDBS serves thousands of users across hundreds of organizations around the globe, including 23 of the top 25 pharmaceutical companies and more than 250 small and medium-sized pharma and biopharma companies, CROs, CDMOs, and CMOs.
Körber Pharma Software, formerly Werum IT Solutions, is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Our out-of-the-box PAS-X software is run by the majority of the worlds to 30 pharmaceutical and biotech companies and by many mid-sized manufacturers.
Our software product, Werum PAS-X MES, is recognized as the world’s leading Manufacturing Execution System (MES) for the pharma, biotech and cell & gene therapy industries. We offer a full-scope MES solution comprising the PAS-X software product and pre-configured content for pharmaceutical, biotech and cell & gene processes completed by consulting, training and support services.
Körber is an international technology group with about 13,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. At the Körber Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions.
MasterControl Inc. provides cloud-based software to empower manufacturers in life sciences and other regulated industries to digitize and streamline their processes to reduce errors on the shop floor. Our mission is to help our customers bring life-changing products to more people sooner.
Manufacturing Excellence is a modern MES designed to simplify manufacturing execution for manufacturers of all sizes. It delivers proven results in the metrics that matter – from faster review and release, more throughput, and fewer human errors. Learn how to take a smarter approach to manufacturing at mastercontrol.com.
Precision NanoSystems, now part of Cytiva, is a global leader in ushering in the next wave of genomic medicines in infectious diseases, cancer, and rare diseases. We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genomic medicines.
Project Farma is an industry leader in providing project management, validation, engineering and consulting services with a proven track record in gene and cell therapy. We partner with gene and cell therapy organizations in addition to healthcare, pharmaceutical, bio-pharmaceutical companies to support finding ground-breaking treatments and solutions. Our gene and cell therapy clients include early stage startups, establish cell and gene therapy companies and CMOs / CROs. We are committed to helping advance cutting-edge medicines by leveraging our deep knowledge and broad experience in cell and gene therapy to meet any new challenges.
SmartLabs provides teams of all sizes enterprise-grade labs customized within weeks for any stage of research or modality and can be reconfigured within days as your research evolves. Outsource your infrastructure and avoid the extensive costs of traditional lab builds while your own teams accelerate your research in a private lab.
Applied Materials provides pharma manufacturers an opportunity to leverage decades of experience in increasing productivity. SmartFactory Rx™ is a suite of advanced manufacturing software which enables pharma companies to achieve unprecedented levels of productivity, quality and compliance from their plants and supply chain refined through 30 years of leadership based on Industry 4.0 principles. The suite is a data & application integration platform which provides: advanced process analytics & control, real-time production planning & scheduling, predictive maintenance, and knowledge advisor for creating a continuous learning environment for knowledge capture and reuse. Solutions are rapidly implemented by non-programmers using this intelligent & flexible platform to enable data-driven decisions from the shop floor to top floor.
Boehringer Ingelheim is a leading research-driven biopharmaceutical company and creates value through innovation in areas of high unmet medical need.
As one of the world’s largest manufacturers for biopharmaceuticals with in-depth experience in this field, the company is an industry pioneer and collaborates with top 20 pharma companies and innovative biotechs.
Boehringer Ingelheim BioXcellence™ reliably supplies innovative therapies that transform lives, today and for generations to come. We create solutions with our partners, building on our can-do attitude to improve patient health.
Our business is empowered by 5,000 dedicated and well-trained employees in development, quality and manufacturing and has access to a global manufacturing network providing the entire production chain from DNA to Fill & Finish. Our track records, both in commercial and clinical supply speak for themselves – since we started offering contract manufacturing in 1995, we have successfully brought 40 biologics to the market and have transferred and optimized more than 150 development and manufacturing projects at all stages from our customers to our facilities, as well as within our network.
While collaborating with our partners we never lose sight of the patients that depend on biopharmaceutical therapies. We offer capabilities to complement your expertise, so together we can deliver better therapies.
Dassault Systèmes is a science-driven company committed to leveraging deep sciences for a better future. Under its various brands, the company offers sustainable virtual twin experiences that merge model-based, data-driven, and multi-physics representations.
BIOVIA specializes in creating collaborative environments for advanced biological, chemical, and materials experiences, aiding science-focused businesses in developing superior products efficiently.
DELMIA software bridges the gap between the virtual and real worlds, facilitating collaboration, modeling, optimization, and execution of supply chains, manufacturing, logistics, and services. This integration helps organizations achieve strategic business objectives while ensuring quality and regulatory compliance.
Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com
Vision. Expertise. Success.
AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market.
Drawing on more than four decades of success as the manufacturing division of AbbVie, we have the depth of experience and the technical knowledge to navigate issues and deliver the innovative solutions customers need. We are much more than a CMO – we are your partner for success.
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle. Leveraging 675,000 ft² across five US-based scientific campuses, Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services. Alcami’s private equity ownership includes Madison Dearborn Partners and Ampersand Capital Partners. For more information, please visit alcaminow.com and masy.com.
Founded in 1998, Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients worldwide rely on Aldevron-produced plasmid DNA, RNA, gene editing enzymes and more for biological research projects from discovery to clinical trials and commercial applications. These efforts help accelerate development of treatments for diseases such as cancer, infectious disease, pediatric disorders and rare diseases.
Aldevron specializes in cGMP manufacturing and is known for inventing the GMP-Source® quality system. Our mission is to be a partner in the development of medicines that improve patients’ lives while serving clients, employees, and the community, while constantly looking for new and better ways to give researchers the products and services they need.
Aldevron operates the largest cGMP plasmid DNA manufacturing facility in the world, located in Fargo, North Dakota, which serves as company headquarters, with additional facilities in Madison, Wisconsin, and Lincoln, Nebraska.
Website: www.aldevron.com
Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes. Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.
DCI, Inc., founded in 1955, is a world leading manufacturer of stainless steel storage and processing vessels, agitators, and integrated systems for the food, dairy, beverage, pharmaceutical, biopharmaceutical, biotech, animal health, chemical, cosmetic, and wine industries. DCI’s portfolio of products and services includes tanks, pressure vessels, and processing equipment such as processors, fermenters, bioreactors, silos, horizontal and vertical storage tanks, aseptic media and batch tanks, mixing tanks, whey crystallizers, DCI Dynamixer, and the VARO HPT. In addition to our standard equipment, DCI also custom-engineers and builds equipment to fit your company needs and certifies your tank to meet all your ASME, ASME-BPE, PED, CE, FDA, CRN and 3A requirements.
In April 2019, Emerson acquired Bioproduction Group (Bio-G), a leader in simulation, modeling, and scheduling software for biomanufacturing. Bio-G’s scheduling and modeling systems combined with Emerson’s extensive life sciences technology and expertise portfolio will help companies bring therapies for cancer, diabetes, and other illnesses to patients sooner.
Life sciences companies continually look to accelerate the production of patient therapies and the Bio-G Scheduling software helps them accurately predict future plant resource availability to optimize manufacturing production. The scheduling software delivers an instantaneous view, accessible across an organization, into the current and future state of the plant, providing decision support to help increase facility uptime and reduce schedule-related product losses.
For more information visit www.emerson.com/rtms.
GRAM is a leading parenteral CDMO delivering customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics, small molecules, and vaccines, GRAM’s advanced technology and staff support pharmaceutical development and cGMP manufacturing, analytical testing, and regulatory filing.
For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $20.9 billion and operations in over 80 countries around the world, JLL’s Life Sciences team of 3,000+ experienced professionals help biotech, pharma and med device organizations achieve breakthroughs. Driven by our purpose to shape the future of real estate for a better world, our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. We help our clients, people and communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit us.jll.com
MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company’s technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERTTM platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.
QbDVision is an innovative software company pioneering the development of modern digital solutions for the pharma/biotech industry to accelerate the manufacturing development cycle, increase the probability of technical success, and help get therapeutic breakthroughs to patients that much faster.
For many of the newest therapies being developed, the associated manufacturing processes are complex and the next generation of software solutions need to move the industry away from document-centric and spreadsheet-centric information management. QbDVision has assembled a group of industry veterans with 100+ years of collective experience in process development, tech transfer, pharmaceutical quality, and regulatory compliance to develop the next generation of structured data solutions that will dramatically increase R&D efficiency.
Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.
Scorpius BioManufacturing is an integrated CDMO focused on rapidly advancing your mammalian and microbial biologic programs to the clinic and beyond. With end-to-end capabilities from discovery to limited-scale commercial production, we provide a broad array of R&D, analytical testing, and manufacturing services to pharmaceutical and biotech companies. With an experienced team and new, purpose-built, U.S. facilities, Scorpius is dedicated to easily accessible, transparent collaboration and flexible biologics biomanufacturing.
Sharp is a global leader in pharmaceutical packaging and clinical trial supply services. For 70 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver.
Through our partnership with Berkshire Sterile Manufacturing we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.Learn more at www.sharpservices.com
ValGenesis delivers integrated and smart solutions that support the digital transformation of the life sciences industry. With a portfolio that covers the whole product lifecycle, ValGenesis has a digital or technical solution that brings value to each step of your validation and manufacturing processes and their related activities.
Veeva is the global leader in cloud software for the life sciences industry with a keen focus on quality manufacturing. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs, CDMOs, and contract services. Veeva powers organizations to manage end-to-end quality processes in one easy to use unified cloud solution to drive speed, collaboration, and compliance.
As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
See how Veeva can help you modernize quality manufacturing at veeva.com/qualitymanufacturing
APC helps biopharma companies slash drug development times by delivering breakthrough science at lightning-fast process development speed. We thrive on radical collaboration – challenging ourselves and our clients to deliver for patients faster.
iAchieve, our proprietary, cloud-based knowledge management platform digitizes every aspect of your medicine’s journey from process definition through process characterization and into the manufacturing facility that best suits your needs.
Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync.
With $207M in funding, a 3.4x growth YoY rate, and 218% net customer retention, Apprentice is a trusted partner to modernize your operations and change the way drugs are made in your facility. Learn how leading companies like Synthego and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster at www.apprentice.io.
Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 30 years of experience producing monoclonal antibodies and recombinant proteins, Avid’s services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com
Benchmark Products was founded in 1993 to supply innovative solutions and products that help Life Science manufacturers deliver high-quality therapies to patients. Benchmark provides value added services such as custom kitting, single-use fluid handling assemblies, product irradiation/quality assurance, and cleaning & disinfecting solutions. The company is committed to exceptional quality and is proud to be ISO 9001:2015 certified, along with state-of-the-art ISO Class 7 Cleanroom facilities on site. For more information on our products and services, please visit www.benchmarkproducts.com.
Be The Match BioTherapies® partners with cell and gene therapy companies to save lives through allogeneic cellular therapy. We are the only cell and gene therapy solutions provider with customizable services to support the entire end-to-end cell therapy supply chain. As part of the National Marrow Donor Program®(NMDP)/Be The Match®, Be The Match BioTherapies has sourced, collected and delivered cells from more than 100,000 volunteer allogeneic donors around the world for time-critical cellular therapies. We have extensive experience providing cellular source material consented for research, clinical and commercial use. Throughout the past 35+ years, Be The Match BioTherapies has developed and continually enhanced their cell collection network and proven cell therapy supply chain infrastructure. The teams are responsible for more than 6,500 time-sensitive cell therapy shipments per year. Through the CIBMTR® (Center for International Blood and Marrow Transplant Research®), Be The Match BioTherapies provides long-term follow-up tracking for the first two FDA-approved CAR-T therapies.
Bluecrux is a leading value chain technology and consulting company, providing solutions at “the Cutting X”. Bluecrux experts and software help to transform today’s supply chains into smart, efficient, and fully integrated value chains. Bluecrux offers solutions that fit the unique complexities of businesses in life sciences, consumer goods, chemicals and industrial manufacturing.
Binocs- Bluecrux SaaS solution- is a global provider of AI/ML based orchestrated scheduling and forecast planning needs and has been specifically designed to address the challenges in Cell & Gene therapy industry. Binocs can assist therapy developers in efficiently manage internal and external resources to create a great customer (HCPs) and patient experience by providing real-time updates and information on the development of individual therapeutics. Binocs is already supporting commercial CAR-T and many other late & early stage clinical studies.
Since our founding in 1996, CAI strives to help our clients design, deliver, operate, and maintain quality, critical manufacturing facilities by pooling our global resources of 800+ employee-owners. Our engineering, technical, and consulting services encompass all aspects of operation. We integrate people, process, equipment, systems, and facilities into a high-performance manufacturing operation. The result is a superior level of operational performance and reliability. With offices in the Americas, Ireland, the UK, Italy, Switzerland, China, India, Singapore, Korea, and Australia, we have been able to serve the needs of clients all over the world. CAI is involved in each part of the project when you need to meet a higher standard.
Our service offerings have evolved out of the needs of the customer for 25 years. Every service offering is considered a Business Area. A business area consists of a set of services that requires a unique quality system, a set of personnel with skills and experience, and a potentially unique client base. A business area requires unique knowledge of and approaches to a market segment. Within a business area there may be multiple areas of technical focus; these focus areas are mutually supportive of the business area but are not distinct business areas themselves. CAI serves clients in the following business areas:
The world leader in clean air technology and air filter production, Camfil is the foremost supplier of air filtration, terminal and containment housings to the Life Science industries.
We provide the tools to achieve sustainability, maintain high air quality and reduce airborne contaminants, while lowering total cost of ownership.
Catalent Biologics provides integrated development and manufacturing solutions for biotherapeutics, and cell and gene therapies. With technology platforms including GPEx® cell line engineering, SMARTag® bioconjugation, plasmid DNA, viral vectors, iPSCs and cell therapies, combined with manufacturing, fill/finish, and analytical services, Catalent Biologics is your partner for clinical and commercial success.
Excellos is your cell therapy CDMO, from starting material to commercialization. We provide custom GMP services to develop and manufacture cell therapies. Our deeply characterized cells help reduce variabilities in clinical responses and increase your probability of success. Current applications supported focus on TIL-based therapies, autologous and allogenic CAR-T/NK therapies and TCR therapies. Our customized services include donor recruitment, cell isolation, transduction, expansion and scale up GMP production. Excellos delivers the promise of cell potency.
INCOG BioPharma Services is designed and built based on decades of experience with a clear purpose: to be a customer-driven CDMO providing a new standard of excellence for injectable drug products.
The company’s service offering includes filling drug products into vials, syringes, and cartridges. INCOG BioPharma also offers support services, including analytical development, stability testing and storage, final inspection, labeling, packaging, and device assembly.
We go above and beyond to understand your requirements, meet your needs, and foster a collaborative partnership. Experience better and discover the INCOG way.
At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome, at the time when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just the current, but also the future challenges. Together, we can bring your next medicine to life.
Myra EB Systems is a technology solutions provider that specializes in utilizing AI for target identification, drug development, and supply management. Our platform includes built-in capabilities for data management, inventory control, supply planning, and shipment tracking.
Furthermore, Myra EB Systems is a pioneer in the field of VR technology, offering training solutions for manufacturing. Clients can select from a variety of training libraries to effectively train their workforce.
POMS Corporation’s industry knowledge, validation experience, and MES technology are unparalleled in the cGMP environment. POMS Corporation MES Product set the standard for manufacturing in Pharmaceutical, Biotechnology, Cell & Gene Therapy, Medical Device, Consumer Packaged Goods, and other regulated industries.
POMS is committed to improving the effectiveness, competitiveness, and compliance of regulated manufacturers by delivering proven, world-class manufacturing execution system MES solutions that integrate seamlessly with other enterprise applications.
PQE Group is a leading quality solution provider for the Life Science industry, in both high level and hands on consulting services around the world. With a global presence, the PQE Group supports small, medium and large sized organizations in their development and compliance-related challenges. We are woman-owned a ISO 9001 certified technology solutions and compliance consulting services company with global capabilities deliverable throughout the entire product quality life cycle, allowing us to offer services at a very competitive price.
We are a biotech small business focused on developing customized sensors for water quality and process control applications. Our in-line sensors can track specific targets including nutrients, proteins, and bacteria in real time and provide quantitative data for process control applications.
Separation, Enrichment, Purification. Engineers and scientists come to Rousselet-Robatel when they want robust, performance-based separation & recovery solutions. From kilogram capacities on the R&D laboratory bench up to production demands exceeding metric tons per day, the bio-pharmaceutical range of cGMP centrifuges from Rousselet-Robatel are used in applications requiring solid-liquid phase separation, liquid-liquid extraction and enrichment, and chromatographic purification.
At Selkirk, our goal is to become your most reliable partner for aseptic Fill/Finish services. In our new state-of-the-art facility, we provide high yield manufacturing of your critical products to meet patients’ needs. Our facility is purpose-built for contract manufacturing with unidirectional process flows, advanced SKAN isolators and high yield Bausch & Stroebel filling equipment. Vial capacity currently available.
Wheeler Bio is a biomanufacturing pioneer, founded by a team of industry experts and strategic investors who believe a different CDMO model is needed to help innovators go faster with new therapeutic candidates. Our novel hub-and-spoke concept, centered in Oklahoma City, will revolutionize the speed of drug development.
As the advanced therapies business unit of WuXi AppTec, WuXi Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO) that offers integrated platforms to transform the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world. For more information, please visit www.advancedtherapies.com.
Yposkesi, an SK pharmteco company, is one of Europe’s largest CDMO for cell & gene therapy viral vector manufacturing. A trusted partner for companies seeking to advance clinical trials and commercialize ATMPs, Yposkesi offers a full range of services in LVV and AAV cGMP manufacturing. Within a 50,000 ft2 (soon 100,000 ft2) facility, Yposkesi operates 4 manufacturing suites for bulk DS (up to 1,000 L) and fill & finish. Yposkesi’s investment in innovation ensures that its bioprocessing platforms deliver high-quality gene-modified cell therapies and in vivo gene therapy projects.
3M solutions work to optimize your processes, applying our biopharma experience, material science and proprietary technologies to help you develop highly effective purification solutions. Our solutions are designed for upstream and downstream processing. These solutions are focused on 3M innovative technologies for the development and manufacturing of recombinant proteins including mAbs, vaccines, and therapeutic plasma proteins.
Accenture is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions—underpinned by the world’s largest delivery network—Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With 482,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives.
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, using mammalian and microbial production systems.
Our integrated service offerings include cell line development, bioprocess development, formulation, analytical testing, antibody drug development and conjugation, cell banking and storage and protein expression — including our proprietary CHEF1® Expression System for efficient protein production with CHO cells.
Our company DNA drives us to provide innovative solutions for clients to reach their goals and accelerate their projects at our cGMP-compliant facilities in the US, Europe and Japan, as well as to facilitate approval and manage spending during the product lifecycle.
We forge exceptionally strong partnerships with our clients and we never lose sight of our commitment to deliver reliable and compliant drug substance. Right. On Time.
OUR MISSION
To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.
OUR VISION
To be the first provider that customers call when they are looking for a Contract Development Manufacturing Organization.
OUR VALUES
Innovation & Operational Excellence
Diversity
Protect the Environment
Integrity
Asimov is a Boston-based company building a horizontal platform for biologics and cell/gene therapy manufacturing. Their 80-person team integrates synthetic biology, mammalian cell engineering (CHO cells, HEK293 cells, and more), and machine learning to solve the key bottlenecks in therapeutics manufacturing and design. For more information please visit our website www.asimov.com.
From Discovery to Delivery™, Azzur Group provides the life science community full life-cycle solutions for all their GxP needs. From Azzur Cleanrooms on Demand™ facilities, to our labs, training centers and consulting offices across the nation, Azzur Group helps organizations start, scale, and sustain their growing enterprises. With nearly four decades of service to the life science community, we have become a trusted partner to the world’s leading pharmaceutical, biotechnology, medical device, and healthcare companies, as well as their supply chain. Follow us on LinkedIn. For more information, visit azzur.com
Boehringer Ingelheim is a leading research-driven biopharmaceutical company and creates value through innovation in areas of high unmet medical need.
As one of the world’s largest manufacturers for biopharmaceuticals with in-depth experience in this field, the company is an industry pioneer and collaborates with top 20 pharma companies and innovative biotechs.
Boehringer Ingelheim BioXcellence™ reliably supplies innovative therapies that transform lives, today and for generations to come. We create solutions with our partners, building on our can-do attitude to improve patient health.
Our business is empowered by 5,000 dedicated and well-trained employees in development, quality and manufacturing and has access to a global manufacturing network providing the entire production chain from DNA to Fill & Finish. Our track records, both in commercial and clinical supply speak for themselves – since we started offering contract manufacturing in 1995, we have successfully brought 40 biologics to the market and have transferred and optimized more than 150 development and manufacturing projects at all stages from our customers to our facilities, as well as within our network.
While collaborating with our partners we never lose sight of the patients that depend on biopharmaceutical therapies. We offer capabilities to complement your expertise, so together we can deliver better therapies.
CoJourney is a CDMO with a strong track record of success in CGT development and manufacturing.
Our optimized platform shortens timelines, lowers costs, and consistently delivers high quality product. Our services support the development, cGMP manufacturing, and analytical testing of plasmids, viral vectors, and mRNA produced in our state-of-the-art manufacturing facilities that meet FDA, EMA, and NMPA guidelines.
Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes. Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Whatman and Xcellerex. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.
Fluor is building a better future by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 41,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. For decades, Fluor has designed and built various types of biotech and bulk pharmaceutical facilities, employing batch, semi continuous, and continuous operations. We offer the life sciences industry agility and robustness through expertise in process design while providing innovative professional and technical solutions.
GC Cell stands at the forefront of cell therapy innovation, offering a holistic approach that encompasses everything from research and development to bringing products to market. Our mission is to fast-track the innovation in cell and gene therapies, aiming to enhance the clinical outcomes of each & every patient and shape the future of healthcare. In collaboration with our affiliates, Artiva and BioCentriq, we possess a distinct competitive edge through (1) outstanding portfolio of CIK T cell and NK cell therapies, (2) a seamless integration from Development to Commercialization, demonstrated by a track record of treating over 10,000 patients with solid tumor, and (3) adherence to global standards through our high-quality CDMO and Cold Chain Supply.
IDA Ireland was founded in 1949 as the Irish Government agency responsible for the attraction and retention of foreign direct investment (FDI) into Ireland. IDA Ireland partners with multinational companies to attract investment, providing jobs for the economic and social benefit of Ireland.
We have partnered with 1,200 companies to establish operations in Ireland, including all the World’s Top 10 Biopharmaceutical companies.
The biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents the biggest wave of investment in new biotech facilities anywhere in the world.
Speak with us and you will soon understand why Ireland has developed Europe’s premier biopharma manufacturing cluster.
L7 Informatics reimagines data intelligence for modern life sciences and healthcare organizations. Beyond simple data management, L7 provides tools that optimize the flow of information between process and people, unlocking innovation at every stage of the clinical, research, and manufacturing value chains. Our comprehensive operating environment and software stack bring flexible, secure, and collaborative data intelligence to your entire operation. From regulatory compliance and workflow orchestration to customized applications and integrations, our end-to-end transformation engine helps organizations solve today’s challenges and realize tomorrow’s opportunities. L7|ESP™ is designed to unlock innovation at every stage of the clinical, research, and manufacturing value chain. From data and workflow orchestration to custom apps and integrations, L7|ESP is an end-to-end transformation engine to help solve today’s challenges and realize tomorrow’s opportunities.
The L7 Manufacturing Execution System (MES) offers a unified platform approach to manufacturing operations management. While traditional MES is rigid and siloed from other systems and equipment, leaving operations still relying on forms and spreadsheets, L7 MES provides a holistic manufacturing operations management experience. Additionally, the L7 MES system is designed for developing and progressing seamlessly to CGMP production. We are CGMP-ready and provide the flexibility to support the early-stage process development, capturing and curating your data resource across your journey to clinical and commercial production.
Matica Biotechnology is a CDMO providing fully integrated cell and gene therapy development and manufacturing services. With industry-leading expertise in GMP manufacturing of bulk and final drug product, cell line development, process development, and assay development, Matica Bio supports its clients with expertise and streamlined operations from bench to filing. Its state-of-art facility in Texas, has redefined excellence in the CDMO domain through innovative technology such as single-use technologies and in-line process monitoring to deliver cell and gene therapies faster, safer and at the highest level of quality. Our mission is to advance therapies from idea to patient.
Minerva is a specialized provider of quality investigation, product development, process characterization, technology transfer, and productivity improvement services for the cell and gene therapy, biotech, and medical device industries.
Employing advanced visual, data, AI, knowledge, and risk management tools and techniques, our teams deliver exceptional results.
OUR BUSINESS PROPOSITION
Minerva offers a unique approach that ensures successful execution of your quality investigations, product development, technology transfer, and projects support and sustainment with promptness, superior quality, and minimum risk.
QbDVision is an innovative software company pioneering the development of modern digital solutions for the pharma/biotech industry to accelerate the manufacturing development cycle, increase the probability of technical success, and help get therapeutic breakthroughs to patients that much faster.
For many of the newest therapies being developed, the associated manufacturing processes are complex and the next generation of software solutions need to move the industry away from document-centric and spreadsheet-centric information management. QbDVision has assembled a group of industry veterans with 100+ years of collective experience in process development, tech transfer, pharmaceutical quality, and regulatory compliance to develop the next generation of structured data solutions that will dramatically increase R&D efficiency.
ADVANCING BIOPROCESSING
With a culture of innovation, and focused on cost and process efficiencies, Repligen specializes in applications of technologies and solutions that help set new standards in perfusion, process intensification, enhanced vector titer and recovery yield, continuous manufacturing, PAT, SUT and more.
Resilience is a technology-focused manufacturing company dedicated to broadening access to complex medicines. Founded in 2020, the company aims to build a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely and at scale. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience seeks to free its partners to focus on the discoveries that improve patients’ lives.
RSM US LLP is a leading provider of audit, tax, and consulting services focused on the middle market. They serve clients in various industries, including manufacturing, consumer products, technology, financial services, healthcare, and life sciences. RSM US LLP has a team dedicated to serving clients in the life sciences industry, which is known as the Microsoft for Life Sciences team.
The Microsoft for Life Sciences team at RSM US LLP is a group of professionals with expertise in both the life sciences industry and Microsoft technologies. They work closely with clients in the life sciences sector to help them leverage Microsoft solutions for their business needs. This includes implementing and optimizing Microsoft technologies such as Azure, Power BI, Dynamics 365, and Office 365.
The team assists life sciences companies in achieving their digital transformation goals by providing strategic advice and practical guidance. They help clients streamline their operations, improve data analytics and reporting capabilities, enhance collaboration and communication, and strengthen compliance and security measures.
The Microsoft for Life Sciences team at RSM US LLP understands the unique challenges and regulatory requirements of the life sciences industry. They have experience working with pharmaceutical, biotechnology, medical device, and healthcare companies, as well as research organizations. The team is knowledgeable about industry-specific software solutions, regulatory standards, and best practices.
Russell Reynolds Associates is a global search and leadership advisory firm. Our 425+ consultants in 46 offices work with public, private and nonprofit organizations across all industries and regions. We help our clients build teams of transformational leaders who can meet today’s challenges and anticipate the digital, economic and political trends that are reshaping the global business environment. From helping boards with their structure, culture and effectiveness to identifying, assessing and defining the best leadership for organizations – our teams bring their decades of expertise to help clients solve their most complex leadership issues.
Samsung Biologics is a fully integrated CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry. With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.
Our plants are cGMP compliant with a wide range of bioreactor scales to serve varying client needs and meet growing market demand. We hold a total capacity of 604KL at Bio Campus I, the world’s largest biomanufacturing site, and have announced plans to construct a fifth plant, which will be operational in April 2025.
Samsung Biologics is a fully integrated CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry. With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.
Our plants are cGMP compliant with a wide range of bioreactor scales to serve varying client needs and meet growing market demand. We hold a total capacity of 604KL at Bio Campus I, the world’s largest biomanufacturing site, and have announced plans to construct a fifth plant, which will be operational in April 2025.